Correlation Between Annexon and Cognition Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Annexon and Cognition Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annexon and Cognition Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annexon and Cognition Therapeutics, you can compare the effects of market volatilities on Annexon and Cognition Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annexon with a short position of Cognition Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annexon and Cognition Therapeutics.

Diversification Opportunities for Annexon and Cognition Therapeutics

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Annexon and Cognition is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Annexon and Cognition Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cognition Therapeutics and Annexon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annexon are associated (or correlated) with Cognition Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cognition Therapeutics has no effect on the direction of Annexon i.e., Annexon and Cognition Therapeutics go up and down completely randomly.

Pair Corralation between Annexon and Cognition Therapeutics

Given the investment horizon of 90 days Annexon is expected to generate 1.0 times more return on investment than Cognition Therapeutics. However, Annexon is 1.0 times less risky than Cognition Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Cognition Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  467.00  in Annexon on August 31, 2024 and sell it today you would earn a total of  73.00  from holding Annexon or generate 15.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.79%
ValuesDaily Returns

Annexon  vs.  Cognition Therapeutics

 Performance 
       Timeline  
Annexon 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Annexon are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Annexon is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Cognition Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cognition Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Annexon and Cognition Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Annexon and Cognition Therapeutics

The main advantage of trading using opposite Annexon and Cognition Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annexon position performs unexpectedly, Cognition Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cognition Therapeutics will offset losses from the drop in Cognition Therapeutics' long position.
The idea behind Annexon and Cognition Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stocks Directory
Find actively traded stocks across global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios